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D e s p i t e l a r g e numbers of c h i l d r e n with chronic r e n a l f a i l u r e , t h e r e i s i n s u f f i c i e n t information about GF p r i o r t o end s t a g e r e n a l d i s e a s e . I t h a s been s t a t e d t h a t a GFR (ml/min/1.73~2) of 20-25 i s t h e t h r e s h o l d below which growth r e t a r d a t i o n begins.
We r e p o r t t h e l i n e a r growth i n 11 p r e p u b e r t a l c h i l d r e n w i t h s t a b l e MRI f o r a t l e a s t I y e a r (34.4224.4 mos., mean S D ) .
Height was measured w i t h a w a l l s t a d i o m e t e r . MRI was defined a s a GFR between 20-40.
The GFR was a s s e s s e d u s i n g t h e endogenous c r e a t i n i n e c l e a r a n c e o r a l e n g t h e s t i m a t i o n , There were 7 male and 4 female p a t i e n t s , mean age 9.3 y e a r s a t o n s e t . Six c h i l dr e n had c o n g e n i t a l and 5 had acquired c a u s e s o f MRI. The GFR was i n i t i a l l y 32.5+6.4 and d e c l i n e d t o 26.7+6.5 a t t h e end of follow-up.
The mean serum ~a * was 9.4, ~0;=4.4 mg1dL and HCO3-23.8 m~q /~. The PTH l e v e l was e l e v a t e d i n a l l 7 c h i l d r e n w i t h t h e determination.
During t h e o b s e r v a t i o n p e r i o d , 9/11 c h i l d r e n s u f f e r e d GF. T h e i r mean cumulative l o s s of s t a t u r e f o r age was 0 . 6 5 g . 4 4 SD.
The h e i g h t SD f e l l a t a mean y e a r l y r a t e of 0.25511. T h i s i s n e a r l y 65% of t h e mean annual l o s s of l e n g t h f o r age i n d i a l y s i s p a t i e n t s , a s r e p o r t e d by t h e EDTA R e g i s t r y . We conclude t h a t 1 ) s t a b l e MRI i s a s s o c i a t e d with p r o g r e s s i v e l o s s of l i n e a r growth f o r age; and 2) t h e degree of GF approaches t h a t obsenred i n c h i l d r e n on maintenance hemodialysis. Hyperparathyroidism and chronic metabolic a c i d o s i s may be c o n t r i b u t i n g f a c t o r s t o t h i s GF.
of the USA Collaborative Study of Reflux in Children.* VUR accounts for 15% of children and young adults with ESRD and i t is a common cause of severe hypertension in the same population. Since 1980, we have conducted an international, prospective, randomized trial of early anti-reflux surgery (S) vs. medical therapy (M), namely, continous antibiotic chemoprophylaxis. The study population consists of children up t o 10 years of a g e with primary VUR, grade IV/V (International Classification). The end points of t h e trial are: 1) renal growth, a s measured by planimetry, 2) progression of renal scarring or development of new scars, 3) individual kidney GFR, a s measured by DMSA renal scans, 4) r a t e of resolution of VUR in patients treated medically, 5 ) incidence of UTI, 6) incidence of hypertension. To date, 300 pts. have been enrolled. Preliminary analysis of the 116 USA pts. has yielded the following information: 42% of pts have a t least I renal scar a t entry; new or progressive scars were seen in 36% of M p t s vs 50% of S p t s when entry urograrns were compared to those done 6 mo. later (p > .1). By 18 mo. of follow-up, grade IVlV VUR was still present in 83% of t h e p t s in t h e M group. The incidence of a c u t e pyelonephritis was I per 0.007 pt-months a t risk in the S group, and 0.013 for M p t s (p >.I). Only I p t has developed BP > 95th percentile for age and sex during 1 8 mo.
follow-up. Six p t s allocated to M have undergone anti-reflux surgery because of recurrent UTIs and I pt allocated to S has required reoperation for persistent VUR. Thus, no dramatic differences in course between M and S a r e apparent a t this early analysis. Hypertension i n HUS may occur a c u t e l y o r a s a chronic sequela.
The hypertension appears t o be mediated i n p a r t by r e n i n .
For t h i s reason c a p t o p r i l , an a n g i o t e n s i n converting enzyme i n h i b i t o r , i s a p p r o p r i a t e and experience with i t s use i n a few i n d i v i d u a l p a t i e n t s h a s been r e p o r t e d .
We present t h e s u c c e s s f u l management of hypertension by c a p t o p r i l i n 4 p a t i e n t s with HUS. P e r t i n e n t d a t a a r e summarized:
Pre-Cap. ( t a f t e r 18 mos. on c a p t o p r i l ) I n p a t i e n t s 1 and 2 c a p t o p r i l alone was used during t h e a c u t e d i s e a s e .
I n ~a t i e n t s 3 and 4 c a p t o~r i l with a d i u r e t i c was e f f e c t i v e f o r management of chronic hypertension present more than a y e a r following t h e a c u t e i l l n e s s .
C a p t o p r i l may produce hyperkalemia v i a a l d o s t e r o n e i n h i b it i o n .
Serum potassium was modestly e l e v a t e d i n p a t i e n t s 1 and 2 but resolved a f t e r d i s c h a r g e d e s p i t e continued c a p t o p r i l therapy.
Renal f u n c t i o n a s determined by c r e a t i n i n e d i d not d e t e r i o r a t e upon i n s t i t u t i o n o f c a p t o p r i l .
In summary, c a p t o p r i l i s e f f e c t i v e i n both a c u t e and chronic hypertension r e l a t e d t o HUS. 
Hyperlipidemia (HL), p a r t i c u l a r l y e l e v a t e d t r i g l y c e r i d e s (TG) i s f r e q u e n t l y seen i n uremic p a t i e n t s undergoing d i a l y s i s . Carnit i n e p l a y s a n important r o l e i n t h e u t i l i z a t i o n of f a t t y a c i d s and, being a small molecule, i t s p o s s i b l e l o s s e s i n d i a l y s i s
e f f l u e n t may be a c o n t r i b u t i n g f a c t o r t o HL. We s t u d i e d s i m u l t aneous c o n c e n t r a t i o n s of f r e e c a r n i t i n e (FC) and t o t a l c a r n i t i n e (TC) i n plasma ( p r e and p o s t HD) and d i a l y s i s e f f l u e n t i n 9 HD p a t i e n t s (% a g e : I8 y e a r s ) and 5 CAPD p a t i e n t s (x age 10 y e a r s ) . Serum TG were determined i n a l l p a t i e n t s . R e s u l t s (R + SD) a r e summarized i n t h e t a b l e ( t p <0.01 compared t o c o n t r o l s 55+12 60+25 These r e s u l t s demonstrate: 1 ) s i g n i f i c a n t removal of TC during d i a l y s i s ( g r e a t e r on HD than CAPD), but maintenance o f normal plasma TC l e v e l s ; 2) s i g n i f i c a n t d e c r e a s e of plasma FC and TC immediately following HD and 3) HL with s i g n i f i c a n t e l e v a t i o n of TG i n both groups. It i s suggested t h a t cumulative Te l o s s e s d u r i n g d i a l y s i s may aggravate HL i n t h e s e p a t i e n t s . 
PLASMA INFUSIONS ( P I ) IN THE MANAGEMENT OF HEMOLYTIC UREMIC SYNDROME (HUS). Gaston
I n s p i t e of e a r l y d i a l y s i s and s u p p o r t i v e therapy, c h i l d r e n w i t h s e v e r e HUS have a high incidence of s e q u e l a e with c h r o n i c r e n a l f a i l u r e (CRF) and/or hypertension. Previous experience a t t h i s c e n t e r has shown 66% of c h i l d r e n w i t h HUS developing CRF. S i n c e a plasma f a c t o r d e f i c i e n c y has been p o s t u l a t e d i n t h e pathogenesis of t h i s syndrome, we s t u d i e d t h e a c u t e and long term e f f e c t s of P I i n HUS. S i x c h i l d r e n (3 boys) 2-5 y e a r s of age w i t h HUS were t r e a t e d w i t h p e r i t o n e a l d i a l y s i s and P I .
Mean dose of P I was 25 mllKglday given f o r 2-7 days. A l l c h i l d r e n had o l i g o a n u r i a >24 hours ( 2 d u r a t i o n 1 5 days; range 2-30 days) and thrombocytopenia (lowest p l a t e l e t count x 17,500; range 8,000-40,000). Mean serum c r e a t i n i n e b e f o r e d i a l y s i s was 6.2 mgldl. T r a n s i e n t h y p t e r t e n s i o n was p r e s e n t i n a l l t h e p a t i e n t s and two had evidence of multi-organ involvement. A f t e r t h e i n i t i a l dose of P I , p l a t e l e t count r o s e t o >100,000 i n ii 4 days and o l i g oa n u r j a r e s o l v e d i n x 10 days. T o t a l d u r a t i o n of d i a l y s i s period was x 12 days (range 3-30 d a y s ) . At l a s t f o l l o w up (2 1 3 months) a l l s i x c h i l d r e n have serum c r e a t i n i n e 9 . 8 mg/dl (estimated GFR >75 ml/min/1.73 m2) and only two have mild hypertension and p r o t e i n u r i a . These r e s u l t s suggest t h a t j u d i c i o u s a d m i n i s t r at i o n of plasma has a b e n e f i c i a l e f f e c t i n HUS by a c c e l e r a t i n g recovery from t h e a c u t e phase and improving i t s f i n a l outcome. In eye's syndrome ( R S ) -t h e r e is a -g e n e r a l d e c r e a s e i n t h e spec i f i c a c t i v i t i e s of mitochondria1 enzymes, i n c l u d i n g two o f t h e urea c y c l e , carbamyl phosphate s y n t h e t a s e and o r n i t h i n e carbamylt r a n s f e r a s e . These two enzymes c a t a l y z e the s y n t h e s i s o f c i t r u ll i n e (CIT) from o r n i t h i n e , NH3, and C02; t h e f u n c t i o n a l impairment o f t h i s r e a c t i o n sequence probably c o n t r i b u t e s t o hyperammonemia i n RS. S a l i c y l a t e (SA) has been implicated a s a s y n e r g i s t i c fact o r i n t h e pathogenesis of RS. In t h i s s t u d y we i n v e s t i g a t e d whether SA i n h i b i t s CIT s y n t h e s i s i n i s o l a t e d r a t l i v e r mitochond r i a . CIT s y n t h e s i s was assayed a t 370C by measuring 14c02 f i x at i o n i n t h e oresence o f o r n i t h i n e and NHq (ABB 178:19,1977 ). SA 
